Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
28 oct. 2020 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an amendment to its License, Development and Commercialization Agreement (“Agreement”)...
Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results
14 août 2020 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
Acura Pharmaceuticals Announces First Quarter 2020 Financial Results
29 juin 2020 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., June 29, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
30 mars 2020 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., March 30, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
Acura Pharmaceuticals Provides an Update on the Development of LTX-03
23 mars 2020 16h10 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., March 23, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), today announced that Abuse Deterrent Pharma, LLC, its licensee of LTX-03 (Hydrocodone Bitartrate and...
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results
28 févr. 2020 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of...
Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results
10 févr. 2020 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
Acura Pharmaceuticals Provides an Update on the Development of LTX-03
02 janv. 2020 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today provided an update on its development of LTX-03 (Hydrocodone Bitartrate and Acetaminophen)...
Acura Pharmaceuticals Announces First Quarter 2019 Financial Results
01 oct. 2019 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...
Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results
16 sept. 2019 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and...